

Date: Thursday, February 16, 2023
Time: 2:30 – 3:30 p.m.
Location: Live via Zoom
ACPE Credit: Accredited for 1.0 contact hour (see below for instructions on how to claim credit)
Date: Thursday, February 16, 2023
Time: 2:30 – 3:30 p.m.
Location: Live via Zoom
ACPE Credit: Accredited for 1.0 contact hour (see below for instructions on how to claim credit)
PGY-1 Pharmacy Practice Resident
Loma Linda University School of Pharmacy
Updates on CMV management and discussion on the place of the recently approved Livtencity (maribavir) in CMV management. As of 2022, there are only 4 approved medications for use in treatment of CMV infections in transplantation populations: ganciclovir, valganciclovir, cidofovir, and foscarnet. Letermovir is another medication that is only FDA-approved as prophylaxis for CMV. The introduction of maribavir provides an additional option for treatment in CMV in patients who do not respond to standard of therapy in transplantation populations
Upon successful completion of this knowledge-based course pharmacists should be able to:
To obtain 1.0 contact hour of continuing pharmacy education credit (0.1 CEU), participants must participate in the live activities, and log on to the CEimpact website to complete the exam and evaluation.
CEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0107-9999-23-057-L01-P | 0.1 CEUs/1.0 Hrs.
Live Date: February 16, 2023
Faculty Disclosure: The presenter(s) has/have no relevant financial relationships with ineligible companies to disclose.
Course Format: Live, In-Person
Financial Support: None
Course Fee: This course is available at no cost.